← Back to Clinical Trials
Recruiting NCT06531928

NCT06531928 Effect of Chest Tube Withdrawal on Patients' Anxiety Levels After Thoracic Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06531928
Status Recruiting
Phase
Sponsor Ankara Ataturk Sanatorium Training and Research Hospital
Condition Chest Tube Withdrawal
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2024-08-15
Primary Completion 2025-06-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL
Interventions
chest tube withdrawal

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 60 participants in total. It began in 2024-08-15 with a primary completion date of 2025-06-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Since the removal of the chest tube is a painful procedure, it can cause serious anxiety in patients. Patients state that chest tube removal is among the bad memories they experience. The source of the anxiety may be related to fear and anxiety about the pain caused by the upcoming chest tube removal procedure, or it may be the words they have heard from other patients who have had this experience before. There are a limited number of studies in the literature on anxiety that may occur in patients due to chest tube withdrawal. In addition, studies in the literature did not focus on whether there was a difference between pre-procedure and post-procedure anxiety levels. In this study, it was aimed to investigate the anxiety levels before and after the procedure and the pain levels felt in the patients due to the procedure due to chest tube withdrawal in patients who underwent VATS. In addition, it aimed to investigate whether there is any correlation between pre-procedure anxiety and pain experienced during the procedure. If a correlation is detected, the importance of pre-procedural anxiety management will be better understood, the necessity of interventions such as psychological and pharmacological treatment for anxiety will come to the fore, and new research on this subject will be needed.

Eligibility Criteria

Inclusion Criteria: * The ages of 18-65 * BMI between 18-35 kg/m2 * Who have undergone VATS * Who have a single chest tube inserted during surgery * who have undergone resection with VATS (wedge resection, segmentectomy, lobectomy) Exclusion Criteria: * Who have undergone surgery under emergency conditions, * Who have undergone thoracotomy, decortication, pleural biopsy, * Who constantly use anti-inflammatory or analgesic drugs, * Patients with preoperative chronic pain, * Who have undergone thoracic surgery before, * Patients with a history of chest tube insertion and for any reason after surgery (prolonged air leakage), * Patients whose chest tube has not been removed for more than 7 days, * Who have undergone pleurodesis * Patients with psychiatric diagnoses or who use psychiatric drugs * Who are illiterate will be excluded from the study.

Contact & Investigator

Central Contact

Ramazan Baldemir, Specialist

✉ baldemir23@yahoo.com

📞 +905303570166

Frequently Asked Questions

Who can join the NCT06531928 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Chest Tube Withdrawal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06531928 currently recruiting?

Yes, NCT06531928 is actively recruiting participants. Contact the research team at baldemir23@yahoo.com for enrollment information.

Where is the NCT06531928 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye).

Who is sponsoring the NCT06531928 clinical trial?

NCT06531928 is sponsored by Ankara Ataturk Sanatorium Training and Research Hospital. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology